Unicycive Therapeutics Files 2024 Annual Report
Ticker: UNCY · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
Unicycive Therapeutics filed its 2024 10-K. Check financials.
AI Summary
Unicycive Therapeutics, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offices in Los Altos, CA, operates in the Pharmaceutical Preparations sector. The filing details its financial performance and business operations for the year.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Unicycive Therapeutics' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Unicycive Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for financial statements.)
- 650-351-4495 — Business Phone (Contact number for the company's principal executive offices.)
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 2024 (date) — Fiscal year end
- Los Altos, CA (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-40582 (commission_file_number) — SEC file number
FAQ
What is the primary business of Unicycive Therapeutics, Inc.?
Unicycive Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
For which fiscal year is this 10-K report filed?
This 10-K report is filed for the fiscal year ended December 31, 2024.
Where are Unicycive Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of Unicycive Therapeutics, Inc. are located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
What is the company's state of incorporation?
Unicycive Therapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Unicycive Therapeutics, Inc.?
The SEC file number for Unicycive Therapeutics, Inc. is 001-40582.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).